Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis
Objective: To investigate the prevalence of Parkinson disease and myasthenia gravis co-occurrence among hospitalized patients in the United States. Background: Parkinson disease (PD), a largely…A unique genetic duality: GAK and SCN4A Mutations in Myasthenic Syndrome and Early-Onset Parkinsonism in a Peruvian woman: A Case Report
Objective: To present the first genetically characterized non-linear summative damage characterized case resulting in early-onset parkinsonism associated with congenital myasthenia Background: The GAK (Cyclin G…Co-existence of Myasthenia Gravis and Parkinson’s disease, plus essential tremor in a veteran at Camp Lejeune
Objective: We report a unique case of a patient with concurrent myasthenia gravis and Parkinson’s disease, with a history of environmental exposure to organic solvents…Deep Brain Stimulation From the Perspective of Relatives and Caregivers: A Qualitative Analysis and Caregiver Burden
Objective: One of the most important conditions for success in Deep brain stimulation (DBS), which has been proven effective for more than thirty years and…Spastic Ataxia Associated with Congenital Myasthenia Related to the VAMP1 Gene: Report of an Affected Family in Brazil.
Objective: To describe a family with both congenital myasthenia and spastic ataxia Background: The vesicle-associated membrane protein - VAMP1 is associated with synaptic activation in…Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease
Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…Parkinson’s disease and Myasthenia Gravis: a case report and literature review
Objective: To present a case of comorbid Parkinson’s disease(PD) and Myasthenia Gravis(MG) and review the literature about the underlying pathogenesis mechanisms and potential treatments. Background:…D-penicillamine induced myasthenia gravis – the possible complication of Wilson’s disease treatment.
Objective: D-penicillamine (DPA) belongs to the most frequently used drugs in Wilson’s disease (WD) treatment. Despite the effectiveness in WD treatment, DPA could be involved in many…Traveling through the telescope: a neuromuscular and a movement disorders reunion
Objective: We aim to raise awareness to an uncommon but possible combination of Parkinson Disease (PD) and Myasthenia Gravis (MG). Background: The co-occurrence of PD…DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis
Objective: We present a unique clinical case of antibody positive Muscle Specific Kinase (MuSK) Myasthenia Gravis and DaT scan positive Parkinson's Disease to highlight the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.